The colony‐stimulating factor 1 (CSF‐1) pathway has sparked interest to block tumor recruitment of macrophages into TAMs,11 and multiple clinical trials are underway for agents targeting the CSF‐1 pathway for cancer treatment (NCT02829723, NCT02452424, NCT01349049). The gene discussed is CSF1; the disease is neoplasm.